These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Owens DM; Watt FM Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366 [TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598 [TBL] [Abstract][Full Text] [Related]
8. alpha3beta1 and alpha6beta4 integrin receptors for laminin-5 are not essential for epidermal morphogenesis and homeostasis during skin development. DiPersio CM; van der Neut R; Georges-Labouesse E; Kreidberg JA; Sonnenberg A; Hynes RO J Cell Sci; 2000 Sep; 113 ( Pt 17)():3051-62. PubMed ID: 10934043 [TBL] [Abstract][Full Text] [Related]
9. Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. Hobbs RM; Silva-Vargas V; Groves R; Watt FM J Invest Dermatol; 2004 Sep; 123(3):503-15. PubMed ID: 15304090 [TBL] [Abstract][Full Text] [Related]
10. CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis. Winkler AE; Brotman JJ; Pittman ME; Judd NP; Lewis JS; Schreiber RD; Uppaluri R Cancer Res; 2011 Sep; 71(17):5707-16. PubMed ID: 21734014 [TBL] [Abstract][Full Text] [Related]
11. Induced keratinocyte hyper-proliferation in alpha2beta1 integrin transgenic mice results in systemic immune cell activation. Teige I; Bäcklund A; Svensson L; Kvist PH; Petersen TK; Kemp K Int Immunopharmacol; 2010 Jan; 10(1):107-14. PubMed ID: 19840869 [TBL] [Abstract][Full Text] [Related]
12. Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion. Oberyszyn TM; Conti CJ; Ross MS; Oberyszyn AS; Tober KL; Rackoff AI; Robertson FM Carcinogenesis; 1998 Mar; 19(3):445-55. PubMed ID: 9525279 [TBL] [Abstract][Full Text] [Related]
13. The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Baudoux B; Castanares-Zapatero D; Leclercq-Smekens M; Berna N; Poumay Y Eur J Cell Biol; 2000 Jan; 79(1):41-51. PubMed ID: 10711425 [TBL] [Abstract][Full Text] [Related]
15. Protein kinase C delta overexpressing transgenic mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas: a possible link to specific cytokines and cyclooxygenase-2. Aziz MH; Wheeler DL; Bhamb B; Verma AK Cancer Res; 2006 Jan; 66(2):713-22. PubMed ID: 16424000 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers. Vasunia KB; Miller ML; Puga A; Baxter CS Carcinogenesis; 1994 Apr; 15(4):653-60. PubMed ID: 8149476 [TBL] [Abstract][Full Text] [Related]
17. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Greenhalgh DA; Wang XJ; Donehower LA; Roop DR Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135 [TBL] [Abstract][Full Text] [Related]
18. Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene. Blessing M; Nanney LB; King LE; Hogan BL Teratog Carcinog Mutagen; 1995; 15(1):11-21. PubMed ID: 7604388 [TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Reddig PJ; Dreckschmidt NE; Zou J; Bourguignon SE; Oberley TD; Verma AK Cancer Res; 2000 Feb; 60(3):595-602. PubMed ID: 10676642 [TBL] [Abstract][Full Text] [Related]